| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 51.47 mm | 51.47 mm | 51.47 mm | 51.47 mm | 51.47 mm | 51.47 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 4.19 mm | 4.05 mm | 3.42 mm | 3.14 mm |
| Cash used (since last report) | n/a | n/a | 8.71 mm | 8.43 mm | 7.12 mm | 6.53 mm |
| Cash remaining | n/a | n/a | 42.76 mm | 43.04 mm | 44.35 mm | 44.94 mm |
| Runway (months of cash) | n/a | n/a | 10.2 | 10.6 | 13.0 | 14.3 |
| 13F holders | Current |
|---|---|
| Total holders | 118 |
| Opened positions | 36 |
| Closed positions | 3 |
| Increased positions | 38 |
| Reduced positions | 16 |
| 13F shares | Current |
|---|---|
| Total value | 119.12 bn |
| Total shares | 31.73 mm |
| Total puts | 202.60 k |
| Total calls | 866.10 k |
| Total put/call ratio | 0.2 |
| Largest owners | Shares | Value |
|---|---|---|
| Commodore Capital | 5.38 mm | $23.37 bn |
| BlackRock | 2.84 mm | $12.33 bn |
| PFE Pfizer | 2.41 mm | $10.47 bn |
| Vanguard | 2.28 mm | $9.92 bn |
| Acorn Bioventures | 1.95 mm | $0.00 |
| Venrock Healthcare Capital Partners III | 1.71 mm | $29.66 mm |
| Orbimed Advisors | 1.54 mm | $6.68 bn |
| Acorn Capital Advisors | 1.44 mm | $6.26 bn |
| Adage Capital Partners GP, L.L.C. | 1.29 mm | $5.61 bn |
| Geode Capital Management | 982.88 k | $4.27 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 18 Dec 24 | Levine James E. | Common Stock | Buy | Acquire P | Yes | No | 5 | 2,400 | 12.00 k | 67,716 |
| 17 Dec 24 | Levine James E. | Common Stock | Buy | Acquire P | Yes | No | 5.4162 | 2,752 | 14.91 k | 65,316 |
| 16 Dec 24 | Levine James E. | Common Stock | Buy | Acquire P | Yes | No | 3.83 | 2,564 | 9.82 k | 62,564 |
| 12 Dec 24 | Tannenbaum Renee P | Common Stock | Buy | Acquire P | No | No | 3.4224 | 10,000 | 34.22 k | 20,000 |
| 11 Dec 24 | Pace Gary W | Common Stock | Buy | Acquire P | Yes | No | 2.6 | 11,500 | 29.90 k | 1,059,376 |
| 11 Dec 24 | Pace Gary W | Common Stock | Buy | Acquire P | No | No | 2.6 | 350,115 | 910.30 k | 1,047,876 |
| 27 Jun 24 | Mani Mohindru | Stock Options Common Stock | Grant | Acquire A | No | No | 2.33 | 29,700 | 69.20 k | 128,201 |
| 27 Jun 24 | Tannenbaum Renee P | Stock Options Common Stock | Grant | Acquire A | No | No | 2.33 | 29,700 | 69.20 k | 128,201 |
